D1 Capital Partners »

Lexeo Therapeutics shares owned by D1 Capital Partners

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by D1 Capital Partners from 13F filings

Historical chart of D1 Capital Partners investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by D1 Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by D1 Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $39M 2.5M 15.68
2023-12-31 $34M 2.5M 13.42

More positions owned by D1 Capital Partners

Maplebear (CART)
Philip Morris International (PM)
Equity Residential Sh Ben Int (EQR)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Hdfc Bank Sponsored Ads (HDB)
Anthem (ELV)
Live Nation Entertainment (LYV)
Invitation Homes (INVH)
Pfizer (PFE)
Warby Parker Cl A Com (WRBY)
Constellation Brands Cl A (STZ)
Insulet Corporation (PODD)
Spotify Technology S A SHS (SPOT)
Nu Hldgs Ord Shs Cl A (NU)

View all positions for D1 Capital Partners

Top funds holding Lexeo Therapeutics

Eventide Asset Management
Henderson Group
Citadel Advisors
D1 Capital Partners
Omega Fund Management
Novo A/S
Braidwell
Adage Capital Partners GP
Vestal Point Capital
Woodline Partners
Blackstone Group
BlackRock
RA Capital Management
Vanguard Group
Artal Group

View all funds holding Lexeo Therapeutics